API | erwinia asparaginase

erwinia asparaginase (Erwinaze) Report issue

Biological Orphan Drug ^FDA Approved ^FDA

AACT ChEMBL DrugBank Drugs@FDA PubChem

Active Ingredient History

NOW

Asparaginase is an enzyme that is used as a medication and in food manufacturing. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In food manufacturing it is used to decrease acrylamide. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules:

asparaginase erwinia chrysanthemi

crisantaspase

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Parenteral
Pro Drug: No

Drug Pricing (per unit)

United States

$4262.6900

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Organizations (34)

Research & Development (31)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (4)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (16)

Approved Indications (1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Experimental Indications - Clinical Trial Phases 1-4 (16)

Allergy and Immunology (Phase 1)

Down Syndrome (Phase 3)

Geriatrics (Phase 1)

Hematologic Neoplasms (Phase 2)

Leukemia (Phase 3)

Leukemia, Biphenotypic, Acute (Phase 2)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 1)

Lymphoma, Large-Cell, Immunoblastic (Phase 3)

Lymphoma, Non-Hodgkin (Phase 2)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 3)

Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma ()

Overview

Highest Phase: Phase 3
# of Trials: 32
# of Trial Organizations: 31

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue